Pharmacological approaches to the modulation of plasma cholesterol
- 30 September 1988
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 9 (9) , 326-329
- https://doi.org/10.1016/0165-6147(88)90104-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA, 1987
- Diet, Lipoproteins, and the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1985
- Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.BMJ, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research GroupJAMA, 1982
- Effect of neomycin sulphate alone and in combination with d-thyroxine on serum lipoproteins in hypercholesterolaemic subjectsEuropean Journal of Clinical Pharmacology, 1982
- The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients.Circulation, 1981
- Effects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol and Fecal Steroids in Hypercholesterolemic SubjectsJournal of Clinical Investigation, 1979
- Treatment of Hypercholesterolemia with Neomycin — A Time for ReappraisalNew England Journal of Medicine, 1979